GENEVA, July 2 -- ENTRADA THERAPEUTICS, INC. filed a patent application (US2025/060756) for “PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER CONJUGATE COMPOUNDS AND THEIR USE IN TREATING MYOTONIC DYSTROPHY TYPE 1”. With publication no. WO/2026/136946, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/64
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....